Dafin maciji yana da abubuwa da yawa na bioactive, galibi sun haɗa da protease da polypeptide
Yana lissafin kusan 90% ~ 95% na busasshen nauyin dafin maciji [l
Tare da ci gaba da haɓakar fasaha, yawancin sunadaran sunadarai masu aiki a cikin dafin maciji suna sannu a hankali
An ware kuma an tsarkake shi, kuma mutane sun yi
A gudanar da bincike mai zurfi a kansa da nufin amfani da ingantattun sinadaran da ke cikin dafin maciji ga mutane.
A cikin maganin cututtuka irin wannan.A halin yanzu, abubuwan da ke aiki na magunguna masu tasiri waɗanda ke cikin dafin maciji
Binciken miyagun ƙwayoyi da aikace-aikacen asibiti da aka gudanar sun fi mayar da hankali kan antithrombotic, hemostatic da hypoglycemic
Matsi, maganin ciwon daji da magungunan kashe zafi.
L Magungunan Antithrombotic
Dafin maciji tare da anti-thrombotic da thrombolytic effects yafi hada da Ancelor
Enzyme (hoe crod), batmxobin, defibrase (de coerase) da Agkistrodon acutus.
Enzyme (acutobin).Uku na farko na snaI [e venom
Thmmbin kamar enzynles, s Ⅷ.E), sVTLE shine serine protease, iri ɗaya da
Yana da arginine esterase da amidase aiki - 1. dafin maciji thrombin-kamar enzyme.
Yana aiki akan fibrinogen don sakin fibrinogen A ko B, don haka
Yana iya coagulate da polymerization na fibrin monomer kai da wutsiya, saboda yana nuna thrombin
Aiki kuma ana kiransa thrombin-kamar.A lokaci guda, ba a iya samun dafin maciji mai kama da thrombin a cikin mutane
Yana kunna coagulation factor x Ⅲ a cikin vivo, kuma fibrin monomer da aka samar ta hanyar hydrolysis na iya
Kai da wutsiya polymerization, amma ba zai iya samar da gefen sarkar giciye-linking, wanda yake da sauki a lalace ta halitta reticuloendothelial tsarin.
An rage matakin fibrinogen na plasma saboda phagocytosis ko lalata ta tsarin fibrinolytic.
Yana cikin yanayin fibrinolytic mara kyau, don haka yana nuna anticoagulation da damuwa a cikin jiki
Fibrillation H1.Agkistrodon acutus enzyme nasa ne na fibrinolytic enzyme, wanda shine fibrinolytic
Ana iya raba taƙaitaccen enzyme [Erin (ogen) ol "icenzyme, FLE] zuwa sarkar guda ɗaya.
Zinc metalloproteinase da sarkar sarka ko sarkar sarka biyu, galibi kwai karfen zinc
Farin enzyme.Dafin maciji fibrinolytic enzyme baya buƙatar kunna kunnawa, kuma yana iya yanke zaruruwa kai tsaye.
Sunadaran (protogen) yana haifar da hemofibrin, don haka ba zai haifar da tarawa ba "J.
Daga dafin Agkistrodon halys (misali sek, № r [md ∞ zuwa, jirgin ruwa) a Malaysia
Ankylose keɓe shi ne na farko da aka yi amfani da shi a cikin maganin cututtuka na thrombotic na asibiti
Farashin SVTLE.6 J. Bayan ci gaban Ancelose, ƙasashe da yawa sun taɓa yin nazarinsa
Masu bincike sunyi imanin cewa sV'11E shine mafi kyawun magani don maganin cututtukan thrombotic,
Bugu da ƙari, ana amfani da shi don maganin thrombosis na gefe, ana iya amfani da shi don maganin thrombosis mai zurfi da jijiyoyi na tsakiya.
Pulse thrombosis kuma yana da tasirin warkewa "J.Zuwa 1990s, ƙasashe da yankuna da yawa
Qu Du yana da matukar sha'awar kula da m cerebral ischemia da bugun jini tare da aclase, da
Aikin kuɗi: Kimiyyar Likitan Soja da Aikin Noman Matasa na Fasaha (13QNP068);Dukan sojojin “12
5 "aikin binciken likita na gaba ɗaya (cwslJ280);Yankin Soja na Chengdu "Shirin Shekaru Biyar na 12" Binciken Likita
Mahimman ayyuka (B12026);Babban aikin binciken likita na yankin soja na Chengdu a lokacin shirin shekaru biyar na 12th
(C12062)
Sashin marubuci: 650032 Kunming, Cibiyar Kula da Cututtuka da Cututtuka ta Yankin Chengdu (Zhang Zhixiao,
Hu Tingsong, Cui Qinghua, Zheng Ying, Fan Quanshui);Pathogens, Makarantar Magunguna ta asali, Kwalejin Kiwon Lafiya ta Youjiang don Ƙasashe
Ofishin Koyarwa da Binciken Halittu da Immunology (Xie Zhenfeng)
Mawallafi mai dacewa: Fan Quanshui, I-mail: fqsl68@126 .com
An gudanar da ƙananan binciken aikace-aikacen asibiti da yawa.Fihirisar kimanta amfani da miyagun ƙwayoyi na farko
Bugu da ƙari, ana iya amfani da Ancelose a cikin maganin asibiti na marasa lafiya tare da ciwon ischemic mai tsanani a farkon mataki
Yana nuna sakamako mai kyau na curative.Bayan haka, tare da manyan sikelin bazuwar makafi biyu, wuribo biyu
Bisa ga gwaji na asibiti, ta, da dai sauransu. Don lokuta 2613 na m
Sakamakon maganin miyagun ƙwayoyi na marasa lafiya tare da bugun jini na ischemic jima'i ya tabbatar da cewa marasa lafiya a cikin ƙungiyar cloroxobin
Adadin tsira ya karu sosai, amma kuma haɗarin zubar jini na ciki ya karu.Bayan haka
Gwajin asibiti na marasa lafiya 1222 tare da bugun jini mai tsanani ya tabbatar da cewa bayan sa'o'i 3
Ba a ba da shawarar Ancelose don magani ba.1…. An buga Amurka da Kanada a cikin 2009
500 bugun jini da ya shafi kasashe da yankuna 12 ciki har da Kanada da Ostiraliya
wahala daga
Lokacin aikawa: Fabrairu-26-2023